It should be added that Yaeger et al51 found higher rates of KRAS (33%) and APC (39%) mutations in intestinal, mainly colorectal, carcinomas associated with Crohn disease in comparison with SB-PCCs related to Crohn disease of our study (0% and 8%, respectively). The gene discussed is KRAS; the disease is Crohn disease.